Sionna Therapeutics Statistics
Total Valuation
SION has a market cap or net worth of $759.27 million. The enterprise value is $414.08 million.
Important Dates
The last earnings date was Monday, May 12, 2025, before market open.
Earnings Date | May 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SION has 44.09 million shares outstanding. The number of shares has increased by 277.77% in one year.
Current Share Class | 44.09M |
Shares Outstanding | 44.09M |
Shares Change (YoY) | +277.77% |
Shares Change (QoQ) | +466.94% |
Owned by Insiders (%) | 1.59% |
Owned by Institutions (%) | 26.49% |
Float | 13.43M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.16 |
P/TBV Ratio | 2.16 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 28.73, with a Debt / Equity ratio of 0.03.
Current Ratio | 28.73 |
Quick Ratio | 28.31 |
Debt / Equity | 0.03 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -21.40% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.62M |
Employee Count | 41 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Dividends & Yields
SION does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -277.77% |
Shareholder Yield | -277.77% |
Earnings Yield | -8.74% |
FCF Yield | -7.38% |
Analyst Forecast
The average price target for SION is $32.00, which is 85.83% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $32.00 |
Price Target Difference | 85.83% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |